Mitsubishi Tanabe Gains Premium Prices For Fingolimod And Telaprevir
This article was originally published in PharmAsia News
Executive Summary
Japan's Chuikyo rewarded the company with better-than-expected NHI listings, but can Mitsubishi Tanabe's sales force shortages help fill demand?